Health Condition 1: K74- Fibrosis and cirrhosis of liver
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients diagnosed with CLD posted for Liver Transplant Surgery
Exclusion criteria
Exclusion criteria: 1. Patient denying consent 2. Known allergy to eggs or propofol 3. Requirement for pretransplant mechanical ventilation 4. Use of vasopressors prior to transplantation. 5. Any modification in anaesthesia treating protocol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the mean target concentration of propofol required to maintain BIS between 40-60 during the three phases of Liver Transplant SurgeryTimepoint: At the end of Dissection Phase - time of portal vein clamping during surgery At the end of Anhepatic Phase - At the time of portal vein unclamping during surgery At the end of Neohepatic Phase - Time of last skin suture during closure of abdomen of the liver transplant surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the total requirement of propofol in each of the three phases of Liver Transplant Surgery in pts with MELD 15-20, 20-25, more than 25Timepoint: End of Dissection Phase - At the time of portal vein clamping during surgery End of Anhepatic Phase - Time of portal vein unclamping during surgery End of Neohepatic Phase - Time of last skin suture during closure of abdomen;To compare the overall total requirement of propofol in pts with MELD 15-20, 20-25, more than 25Timepoint: Time of last skin suture during closure of abdomen | — |
Countries
India
Contacts
Institute of Liver and Biliary Sciences, Delhi